BioCentury
ARTICLE | Clinical News

Pneumostem: Phase I/II start

September 22, 2014 7:00 AM UTC

Next year, Medipost will begin an open-label, U.S. Phase I/II trial to evaluate intratracheal Pneumostem in 12 premature infants at high risk for BPD. The trial will include patients whose gestational...